United States

Astellas opens new headquarters in Illinois, creates 150 jobs

Tuesday, June 5, 2012 08:01 AM

Astellas Pharma U.S., subsidiary of Tokyo-based Astellas Pharma, has opened its new headquarters in Glenview, Ill., serving the Americas.

More... »

Ariana expands operations to U.S.

Monday, June 4, 2012 09:54 AM

France-based Ariana Pharma, a provider of “non-statistical” clinical data analysis technology to the pharmaceutical industry, has expanded its global operations by establishing a permanent U.S. office in Cambridge, Mass., to service growing demand for its powerful data analytics technology KEM.  

More... »

Goodwin Biotech, MD Anderson collaborate on GMP manufacturing of fusion protein conjugate

Monday, June 4, 2012 09:40 AM

Goodwin Biotechnology (GBI) of Plantation, Fla., and the University of Texas MD Anderson Cancer Center have collaborated on process development and GMP manufacturing of a fusion protein composed of a vascular endothelial growth factor (VEGF) and the recombinant toxin, Gelonin (rGel), conjugated to a DOTA chelator.

More... »

AMR offers new “core team” service

Friday, June 1, 2012 02:56 PM

The Alliance for Multispecialty Research (AMR), based in Spring Hill, Tenn., is offering a new gratis service developed by its Alliance of 16 independently owned and managed clinical research centers of excellence across the U.S. and implemented on several recent sponsors' programs, including bioterrorism vaccines, obesity, and tobacco-related projects. 

More... »

Novelos completes first cohort in phase Ib solid tumor trial

Friday, June 1, 2012 10:59 AM

Novelos Therapeutics, a Madison, Wis.-based pharmaceutical company focused on cancer, has successfully completed the first cohort in a multi-center phase Ib dose-escalation trial of its cancer-targeted molecular radiotherapeutic compound I-131-CLR1404 (HOT) in cancer patients with advanced solid tumors. 

More... »

Marina Biotech lays off 90% of staff

Friday, June 1, 2012 10:20 AM

Marina Biotech, a nucleic acid-based drug discovery and development company based in Bothell, Wash., announced that it does not currently have adequate funding to continue implementing its business plan.

More... »

Specialty CRO Agility Clinical is formed

Thursday, May 31, 2012 02:36 PM

David F. Hale, chairman and CEO of Hale BioPharma Ventures, has founded a new CRO, Agility Clinical, in Carlsbad, Calif.

More... »

Zyngenia appoints Frank Hsu as chief medical officer

Thursday, May 31, 2012 02:10 PM

Zyngenia, a Gaithersburg, Md.-based biopharmaceutical company developing next-generation multi-specific antibody-based drugs, has appointed Frank Hsu, M.D., as chief medical officer and a member of its executive team.

More... »

Akesis names John L. Capicchioni as new president

Thursday, May 31, 2012 12:34 PM

Akesis, a Lake Wylie, S.C.-based contract research firm specializing in phase II-IV clinical dermatology services and regulatory affairs consulting, has appointed John L. Capicchioni as its new president.

More... »

Flexion touts positive phase II results for osteoarthritis drug

Thursday, May 31, 2012 12:30 PM

Flexion Therapeutics of Woburn, Mass., has released results from the phase II proof-of-concept trial of its lead osteoarthritis drug candidate, FX005, which demonstrated significant pain relief over placebo at four weeks.

More... »